Bornstein Jonathan 4
4 · Amprius Technologies, Inc. · Filed Apr 3, 2024
Insider Transaction Report
Form 4
Bornstein Jonathan
President of Amprius Lab
Transactions
- Exercise/Conversion
Common stock
2024-04-02$0.05/sh+125,983$6,299→ 684,913 total - Sale
Common stock
2024-04-02$2.38/sh−125,983$299,613→ 558,930 total - Exercise/Conversion
Stock Option (right to buy)
2024-04-02−125,983→ 1,007,868 totalExercise: $0.05From: 2022-09-14Exp: 2027-03-15→ Common stock (125,983 underlying)
Footnotes (3)
- [F1]The exercises and sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2023.
- [F2]The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $2.29 to $2.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]Includes 558,930 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.